Association Between Lipoprotein-Associated Phospholipase A2 and Cardiovascular Disease: A Systematic Review

This publication has 33 references indexed in Scilit:

• Heritability of Coronary Artery Calcium Quantity Measured by Electron Beam Computed Tomography in Asymptomatic Adults
  Circulation, 2002
• Lp-PLA2: an emerging biomarker of coronary heart disease
  Expert Review of Molecular Diagnostics, 2002
• Inhibition of lipoprotein‐associated phospholipase A₂ diminishes the death‐inducing effects of oxidised LDL on human monocyte‐macrophages
  FEBS Letters, 2001
• Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target
  Current Opinion in Pharmacology, 2001
• Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease
  Atherosclerosis, 2000
• Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population
  Atherosclerosis, 2000
• Cellular Source(s) of Platelet-Activating-Factor Acetylhydrolase Activity in Plasma
  Biochemical and Biophysical Research Communications, 1999
• Identification of the G994 → T missense mutation in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men
  Metabolism, 1998
• Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
  New England Journal of Medicine, 1997
• Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.
  Proceedings of the National Academy of Sciences, 1988